Medications for Asthma

162 results

  • Advair

    (fluticasone propionate and salmeterol)
    GlaxoSmithKline LLC
    Usage: ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for acute bronchospasm relief or for patients not adequately controlled on long-term asthma medications.

  • Advair (fluticasone propionate and salmeterol)

    (fluticasone propionate and salmeterol)
    Rebel Distributors Corp.
    Usage: ADVAIR DISKUS is indicated for treating asthma in patients aged 4 and older, and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not for acute bronchospasm relief and should be prescribed to patients inadequately controlled on long-term asthma medications or with severe disease.

  • Advair diskus (fluticasone propionate and salmeterol)

    (fluticasone propionate and salmeterol)
    A-S Medication Solutions
    Usage: ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older, and for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve airflow and reduce exacerbations. It is not intended for acute bronchospasm relief.

  • Advair hfa

    (fluticasone propionate and salmeterol xinafoate)
    GlaxoSmithKline LLC
    Usage: ADVAIR HFA is indicated for the treatment of asthma in adults and adolescents aged 12 and older who are not adequately controlled on long-term asthma medications or require both an inhaled corticosteroid and a long-acting beta2-adrenergic agonist. It is not for acute bronchospasm relief.

  • Albuterol sulfate (albuterol sulfate)

    (Albuterol Sulfate)
    Nephron Pharmaceuticals Corporation
    Usage: Albuterol inhalation solution is indicated for relieving bronchospasm in patients aged 2 to 12 with asthma, a condition characterized by reversible obstructive airway disease.

  • Albuterol sulfate inhalation solution (albuterol sulfate)

    (Albuterol Sulfate)
    Lexenpharm (Suzhou) Limited
    Usage: Albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients aged 2 to 12 years who have asthma or reversible obstructive airway disease.

  • Alvesco

    (ciclesonide)
    Covis Pharma US, Inc
    Usage: ALVESCO is indicated for the maintenance treatment of asthma in adults and pediatric patients aged 12 and older. It is not intended for the relief of acute bronchospasm or for children under 12 years of age.

  • Arnuity ellipta

    (fluticasone furoate)
    GlaxoSmithKline LLC
    Usage: ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and children aged 5 years and older, but is not intended for the relief of acute bronchospasm.

  • Atuss ds tannate suspension (tannate suspension)

    (Tannate Suspension)
    Atley Pharmaceuticals, Inc.
    Usage: Atuss® DS Tannate Suspension is indicated for temporary relief of nasal congestion and cough due to respiratory tract infections, including sinusitis, pharyngitis, bronchitis, and asthma, especially when complicated by thick mucus. It is effective for both productive and nonproductive coughs, particularly beneficial for dry nonproductive coughs.

  • Baycadron (dexamethasone)

    (Dexamethasone)
    Wockhardt USA, LLC
    Usage: This drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., arthritis), collagen diseases, dermatologic diseases, severe allergic reactions, ophthalmic inflammation, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and special cases like tuberculous meningitis and trichinosis.